The stock-market surge has propelled the use of a new kind of tax-loss harvesting. We break it down.

Henry Schein has trailed the broader market over the past 52 weeks, yet Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Why Wall Street loves Micron stock. Citi's PT hike was the larger of the two, nearly doubling since the bank last chimed in, to $840 per share. (But Micron stock only costs $706 t

US stocks could be headed for a "meaningful correction," Morgan Stanley's CIO warns, if the sell-off in bonds continues to drive yields higher.

Here's why the smart money is cautiously bullish on Wells Fargo following the $110 million lending and hiring discrimination settlement.

It leads in the critical equipment used to make chips, and it's seeing solid revenue growth as investment floods into AI data centers. Even though the stock has more than doubled over the past year, Wall Street still appears to be underestimating demand for this company's most advanced chipmaking machines.

The mean of analysts' price targets for Indivior Pharmaceuticals Inc. (INDV) points to a 32.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Stocks have shrugged off war and rising prices, but one Wall Street guru says they can't ignore this huge red flag for long.

Workday (WDAY) shareholders have had a brutal year, and Wall Street keeps adding to the pile. The enterprise software giant has lost more than half its market value since early 2024, and the downgrades have stacked up across the sector as AI agents reshape how analysts model traditional SaaS